2m 2m 2m 2m 2m 2m 2m
RHYTHM PHARM (RYTM)
NASDAQ
$104.77+$0.06 (+0.05%)
Price as of Sep 11, 2026 7:30 PM EDT- $7.2BMarket Cap
- 8.82%1-Year Change
- BiotechnologyIndustry
RHYTHM PHARM (RYTM)
$104.77+$0.06 (+0.05%)
RYTM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $104.71 | ||
Change | +$2.51 (+2.46%) | ||
Open | $102.96 | ||
High | $106.57 | ||
Low | $102.25 | ||
Previous Close | $102.20 | ||
Volume | 573,721 | ||
30-Day Average Volume | 473,932 | ||
1-Week Change | 1.92% | ||
1-Month Change | -7.21% | ||
1-Year Change | 8.82% | ||
3-Year Change | 305.85% | ||
5-Year Change | 706.70% | ||
Fundamentals | |||
Shares Outstanding | 68.9M | ||
Total Assets | $437.3M | ||
Market Cap | $7.2B | ||
Enterprise Value | $7.2B | ||
Period: QTR TTM FY | |||
Revenue | $71.3M | ||
Net Income | -$49.3M | ||
Free Cash Flow | -$9.2M | ||
EBIT | -$48.9M | ||
EBITDA | -$48.7M | ||
Net Working Capital | $303.0M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -149 | ||
Enterprise Value/Revenue | 102 | ||
P/B | 70 | ||
P/E | -143 | ||
PEG | -12 | ||
Price/Free Cash Flow | -788 | ||
Price/Operating Cash Flow | -788 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue